The dust wasn’t settled since AwesomePennyStocks’ fiasco with its last promotion, Vision Plasma Systems Inc (VLNX). VLNX most definitely is on top of “dump-performing” stocks in the OTC’s history. We warned our readers ahead of this dirty game and had many appreciation emails after disaster with VLNX stock.
AwesomePennyStocks is coming with a new pick on Monday:
[note color=”#f3f3f1″]Let’s cut to the chase. The new pick will be announced on Monday.
Premium Members will receive a double alert @ 9:30 AM EST on Monday
An SMS will be sent to their cell phone, and an email to the inbox. This could result in additional gains of 50% or more for our premium members over the regular free newsletter!
If you would like to make a few extra bucks head over to PremiumStockReport and subscribe to the service.
It is critical that when you sign up for the premium membership you use your cell phone number only throughout the registration process in order to get your SMS alert.
Current premium members should have already received an email with instructions on how to add your cell phone number for the free SMS alert.
Subscribe to PremiumStockReport and you WILL receive Monday’s pick before everyone else!
Your AwesomePennyStocks Editor.[/note]
Fool me once, shame on you… Would like to be fooled again?
Well, once again:
[quote style=”1″]Why even bother playing scam stocks (that could be halted at any time) and risking your investment if you have a choice of investing in real companies, with real products, which are on a verge of significant developments.[/quote]
Lpath Inc. (LPTN) has been delayed its renewal of the wet AMD studies which we expected to see at the beginning of August. That said that correspondence with the FDA is not always going as planned. Anyhow, on last Friday, Lpath announced that it has been invited to present at the 2012 Gateway Conference. LPTN management will discuss its pathway to regulatory approval and commercialization of its novel lipidomics-based therapeutics, including the imminent resumption of Phase 2 Nexus’s trial.
Implant Sciences Corporation (IMSC), undervalued investment opportunity, is still on track for the TSA certification. This event WILL take place in upcoming week or in the first week of September. Implant recently announced that its QS-B220 Explosives and Narcotics Trace Detector has successfully completed the certification readiness testing with the Transportation Security Laboratory (“TSL”), the testing body of the Transportation Security Administration (“TSA”). The B220 is now undergoing the final independent validation testing for TSA qualification for air cargo screening.
Are you interested what is next? Big government contracts such as:
[quote style=”1″]TSA has awarded contracts, each potentially worth more than half a billion dollars, to L-3 Communications Security and Detection Systems, Inc. and Morpho Detection, Inc. to supply “medium speed” explosive detection systems that can screen checked baggage turned over by airline passengers.[/quote]
We have been compensated in the amount of ten thousand dollars for profiling Implant Sciences on our site. An affiliate of PennyStockHaven.com receives fifteen thousand dollars per month for providing consulting and advisory services to Implant Sciences, Lpath. We may receive compensation again in the future. This relationship constitutes a conflict and may affect the objectivity of our profile of the company. You should do your own homework and consult an investment professional before making any investment decisions. Read our full disclaimer here.